FR2908133B1 - Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux - Google Patents

Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux

Info

Publication number
FR2908133B1
FR2908133B1 FR0609749A FR0609749A FR2908133B1 FR 2908133 B1 FR2908133 B1 FR 2908133B1 FR 0609749 A FR0609749 A FR 0609749A FR 0609749 A FR0609749 A FR 0609749A FR 2908133 B1 FR2908133 B1 FR 2908133B1
Authority
FR
France
Prior art keywords
nucleotide analogues
precursor molecules
novel nucleotide
antiviral
antiviral precursor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0609749A
Other languages
English (en)
Other versions
FR2908133A1 (fr
Inventor
Bruno Canard
Karine Alvarez
Karine Barral
Jean Louis Romette
Johan Neyts
Jan Balzarini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Aix Marseille Universite
Centre National de la Recherche Scientifique CNRS
Original Assignee
Katholieke Universiteit Leuven
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven, Centre National de la Recherche Scientifique CNRS filed Critical Katholieke Universiteit Leuven
Priority to FR0609749A priority Critical patent/FR2908133B1/fr
Priority to US12/514,285 priority patent/US8884011B2/en
Priority to EP20070859278 priority patent/EP2086990A2/fr
Priority to CA2669450A priority patent/CA2669450C/fr
Priority to JP2009535833A priority patent/JP5584865B2/ja
Priority to PCT/IB2007/004233 priority patent/WO2008056264A2/fr
Publication of FR2908133A1 publication Critical patent/FR2908133A1/fr
Application granted granted Critical
Publication of FR2908133B1 publication Critical patent/FR2908133B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0609749A 2006-11-08 2006-11-08 Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux Expired - Fee Related FR2908133B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0609749A FR2908133B1 (fr) 2006-11-08 2006-11-08 Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
US12/514,285 US8884011B2 (en) 2006-11-08 2007-11-08 Nucleotide analogues as precursor molecules for antivirals
EP20070859278 EP2086990A2 (fr) 2006-11-08 2007-11-08 Analogues de nucléotides innovants en tant que molécules précurseurs d'antiviraux
CA2669450A CA2669450C (fr) 2006-11-08 2007-11-08 Analogues de nucleotides innovants en tant que molecules precurseurs d'antiviraux
JP2009535833A JP5584865B2 (ja) 2006-11-08 2007-11-08 抗ウイルス薬のための前駆体分子としての新規なヌクレオチド類似体
PCT/IB2007/004233 WO2008056264A2 (fr) 2006-11-08 2007-11-08 Analogues de nucléotides innovants en tant que molécules précurseurs d'antiviraux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0609749A FR2908133B1 (fr) 2006-11-08 2006-11-08 Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux

Publications (2)

Publication Number Publication Date
FR2908133A1 FR2908133A1 (fr) 2008-05-09
FR2908133B1 true FR2908133B1 (fr) 2012-12-14

Family

ID=38018742

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0609749A Expired - Fee Related FR2908133B1 (fr) 2006-11-08 2006-11-08 Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux

Country Status (6)

Country Link
US (1) US8884011B2 (fr)
EP (1) EP2086990A2 (fr)
JP (1) JP5584865B2 (fr)
CA (1) CA2669450C (fr)
FR (1) FR2908133B1 (fr)
WO (1) WO2008056264A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2559788B1 (fr) * 2010-04-16 2015-10-14 National University Corporation Okayama University Procédé de production directe d'un dérivé de phosphine à partir d'un dérivé d'oxyde de phosphine
EP3578563B1 (fr) 2011-12-22 2021-04-14 Geron Corporation Analogues de guanine en tant que substrats de télomérase et d'agents affecteurs de longueur de télomère
CN107312039B (zh) 2012-08-30 2019-06-25 江苏豪森药业集团有限公司 一种替诺福韦前药的制备方法
CN104710424B (zh) * 2013-12-11 2017-03-01 河南师范大学 (r)‑(+)‑9‑(2‑羟丙基)腺嘌呤的制备方法
CN104725423A (zh) * 2013-12-18 2015-06-24 山东新时代药业有限公司 一种富马酸替诺福韦二吡呋酯的合成方法
CN105541910A (zh) * 2015-12-21 2016-05-04 山东金城医药化工股份有限公司 对甲苯磺酰氧甲基膦酸二乙酯的合成方法
CN107021985A (zh) * 2017-05-08 2017-08-08 四川理工学院 药物中间体r‑9‑[2‑(二乙氧基膦酰甲氧基)丙基]腺嘌呤的合成方法
EP3730503A4 (fr) * 2017-12-21 2021-05-05 Shenzhen TargetRx, Inc. Inhibiteur nucléosidique de la transcriptase inverse antiviral

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
CS264222B1 (en) * 1986-07-18 1989-06-13 Holy Antonin N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
US4935427A (en) 1987-12-31 1990-06-19 The United States Of America As Represented By The Department Of Health And Human Services Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents
US5072032A (en) 1989-06-21 1991-12-10 Mckenna Charles E Preparation and use of thiophosphonates and thio-analogues of phosphonoformic acid
ATE167679T1 (de) 1990-09-14 1998-07-15 Acad Of Science Czech Republic Wirkstoffvorläufer von phosphonaten
CA2120743C (fr) 1991-10-11 2005-03-08 John C. Martin Derives acycliques purine et pyrimidine de type alkenyl et alkynyl avec un substitut phosphonomethoxyalkyl et ayant une activite antivirale
WO2003002580A1 (fr) * 2001-06-29 2003-01-09 Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic Nouveaux composes et methodes therapeutiques
CN1523028A (zh) * 2003-02-18 2004-08-25 田镇华 一种新型的膦酸酯－核苷酸化合物
SI1644389T1 (sl) * 2003-06-16 2011-06-30 Acad Of Science Czech Republic Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi
CN1634943A (zh) * 2004-11-05 2005-07-06 中国医学科学院医药生物技术研究所 一组非环核苷酸类似物及其合成方法和在抗病毒中的应用
AU2006239677A1 (en) * 2005-04-25 2006-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of compounds to enhance processivity of telomerase
CN100396689C (zh) * 2006-03-07 2008-06-25 中国医学科学院医药生物技术研究所 一组具有抑制hiv-1/hbv病毒复制活性的替诺福韦单酯化合物

Also Published As

Publication number Publication date
CA2669450C (fr) 2016-02-09
JP2010510965A (ja) 2010-04-08
WO2008056264A2 (fr) 2008-05-15
WO2008056264A3 (fr) 2008-10-30
US20100099869A1 (en) 2010-04-22
CA2669450A1 (fr) 2008-05-15
JP5584865B2 (ja) 2014-09-10
EP2086990A2 (fr) 2009-08-12
FR2908133A1 (fr) 2008-05-09
US8884011B2 (en) 2014-11-11

Similar Documents

Publication Publication Date Title
FR23C1051I1 (fr) 2'-fluoro-2'-desoxytetrahydrouridines comme inhibiteurs de cytidine desaminase
FR2908133B1 (fr) Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
DK2066684T3 (da) 5´-Modificerede bicycliske nukleinsyreanaloge
BRPI0718796A2 (pt) Nucleotídeo
BRPI0811710A2 (pt) Troca de nucleotídeo alvo com oligonucleotídes modificados melhorados
ZA201003234B (en) Use of oligonucleotides with modified bases as antiviral agents
EP1996730A4 (fr) Purification de petits arn
ATE538127T1 (de) 6-disubstituierte bicyclische nukleinsäureanaloga
ZA200805141B (en) Improved targeted nucleotide exchange with propynyl modified oligonucleotides
EP1937702A4 (fr) Analogues de nucleotides etiquetes et leurs utilisations
DK2084174T3 (da) Fremstilling af ribofuranosylpyrimidinnukleotider
WO2008150729A3 (fr) Analogues d'acides nucléiques bicycliques pontés par aminométhylène n-substitué
BRPI0921154A2 (pt) 'silenciamento gênico mediado por e coli de beta-catenina'
BRPI0910689A2 (pt) processo de síntese de rna por via química
EP2123752A4 (fr) Nouvel acide nucléique
DK1765844T3 (da) Purin-nukleotidderivater
EP2077326A4 (fr) Nouvel acide nucléique
BRPI0908645A2 (pt) ''processo de purificação de glicerol bruto''
ATE496924T1 (de) Prodrugs von 5-amino-3-(3'-deoxy-beta-d- ribofuranosyl)-thiazolä4,5-düpyrimidin-2,7-dion
EP2082062A4 (fr) Procédés de typage allélique
FR2898646B1 (fr) Structure de queue-d'aronde d'une soufflante.
EP2157182A3 (fr) ARN modifiée à interférences brèves
EP2315857A4 (fr) Procédés et compositions pour le séquençage d acide nucléique monomoléculaire continu par synthèse avec des nucléotides fluorogènes
EP2118297A4 (fr) Génération de molécules d'acide nucléique
FR2915325B1 (fr) Structure d'engagement de connecteurs

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20131002

Owner name: KU LEUVEN RESEARCH & DEVELOPMENT, BE

Effective date: 20131002

Owner name: UNIVERSITE D'AIX-MARSEILLE, FR

Effective date: 20131002

PLFP Fee payment

Year of fee payment: 10

ST Notification of lapse

Effective date: 20170731